Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03367793 · ClinicalTrials.gov registry record · NA
Spectacles for Patients With Down Syndrome
A NA study, sponsored by University of Houston.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03367793 is a NA study that has completed, run by University of Houston. The registered enrollment target is 30 participants.
The verdict
NCT03367793, a NA study, has completed, sponsored by University of Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study tests the hypothesis that objectively derived spectacle prescriptions based on wavefront aberration measurements of the eyes of individuals with Down syndrome can provide an improvement in visual acuity over that obtained with spectacle prescriptions based on standard clinical prescribing techniques. The objectively derived prescriptions are derived using strategies to optimize retinal image quality as measured by image quality metrics, and thus these prescriptions will be referred to as metric-derived.
Interventions
- DEVICE Spectacles - Clinically Derived
- DEVICE Spectacles - Metric Technique #1 Derived
- DEVICE Spectacles - Metric Technique #2 Derived
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-01-26 |
| Est. Completion | 2019-12-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03367793
The ClinicalTrials.gov registry entry for NCT03367793 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Houston, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Spectacles - Clinically Derived is the first listed.
NCT03367793 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03367793 about?
NCT03367793 is a clinical study titled "Spectacles for Patients With Down Syndrome". This study tests the hypothesis that objectively derived spectacle prescriptions based on wavefront aberration measurements of the eyes of individuals with Down syndrome can provide an improvement in visual acuity over that obtained with spectacle prescriptions based on standard clinical prescribing...
What is the current status of trial NCT03367793?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-01-26. Estimated completion is 2019-12-05.
What interventions are being tested in trial NCT03367793?
The interventions under investigation include: Spectacles - Clinically Derived (DEVICE), Spectacles - Metric Technique #1 Derived (DEVICE), Spectacles - Metric Technique #2 Derived (DEVICE).
Who is sponsoring clinical trial NCT03367793?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.